P14-04. HIV-SELECTEST EIA and rapid test: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies

Documenti analoghi

• HIV-Selectest Enzyme Immunoassay and Rapid Test: Ability To Detect Seroconversion following HIV-1 Infection
  di: Khurana, Surender, et al.
  Pubblicazione: (2010)
• Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants
  di: Penezina, Oksana, et al.
  Pubblicazione: (2014)
• Assessment of the ability DS-EIA-HIV-AB-TERM assay correctly identify long-standing and recent HIV infection
  di: Zagryadskaya, YE, et al.
  Pubblicazione: (2014)
• P04-52 LB. The importance of well-defined HIV-1 neutralization assays
  di: Balla-Jhagjhoorsingh, SS, et al.
  Pubblicazione: (2009)
• P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
  di: Brown, BK, et al.
  Pubblicazione: (2009)